GO:0004972 NMDA glutamate receptor activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004972 defines NMDA glutamate receptor activity as a cation channel that opens only when glutamate, glycine or D-serine, and membrane depolarization coincide.
• The receptor is a heterotetramer typically composed of GluN1 and GluN2 subunits, with GluN3 in some complexes.
• NMDA receptor activity is central to synaptic plasticity, learning, and memory, and its dysfunction is linked to neuropsychiatric and neurodegenerative disorders.
• Pharmacological tools such as NMDA, glycine-site agonists, and antagonists like phencyclidine are used to probe receptor function in vitro and in vivo.
• CRISPR-based knockout, point mutation, and knock-in models enable precise dissection of NMDA receptor subunit contributions to physiology and disease.
• EDITGENE provides end-to-end CRISPR services to generate and characterize NMDA receptor-related cell and animal models for mechanistic and translational research.
Description
NMDA glutamate receptor activity (GO:0004972) is a molecular function that describes a ligand-gated cation channel opening in response to simultaneous binding of extracellular glutamate and a co-agonist (glycine or D-serine) under depolarized membrane conditions. This receptor is unique among ionotropic glutamate receptors because it requires coincident detection of neurotransmitter and postsynaptic depolarization, a property that underlies its role as a coincidence detector in synaptic plasticity. Dysregulation of NMDA receptor activity has been implicated in a wide range of neurological and psychiatric conditions, from schizophrenia to chronic pain and neurodegenerative diseases. Understanding the molecular and cellular mechanisms of this receptor is therefore essential for both basic neuroscience and therapeutic development. Researchers rely on pharmacological, genetic, and imaging approaches to study NMDA receptor function, and CRISPR-based models are increasingly used to dissect subunit-specific contributions.
NMDA glutamate receptor activity At A Glance
| GO ID | GO:0004972 |
|---|---|
| GO term | NMDA glutamate receptor activity |
| Ontology | molecular_function |
| Synonym | NMDA receptor, N-methyl-D-aspartate selective glutamate receptor activity |
| Major function | Ligand-gated and voltage-dependent cation channel permeable to Ca2+, Na+, and K+ |
| Co-agonists | Glycine or D-serine required for channel opening |
| Voltage dependence | Indirect, via relief of Mg2+ block at depolarized potentials |
| Subunit composition | Heterotetramers of GluN1 with GluN2 and/or GluN3 subunits |
What Is GO:0004972?
NMDA glutamate receptor activity (GO:0004972) is defined as a cation channel that opens in response to binding by extracellular glutamate, but only if glycine or D-serine is also bound and the membrane is depolarized. Voltage gating is indirect, due to ejection of bound magnesium from the pore at permissive voltages. This definition captures the dual ligand and voltage dependence that distinguishes NMDA receptors from other glutamate receptors.
Why Is NMDA glutamate receptor activity Important in Cell Biology?
NMDA glutamate receptor activity is a fundamental molecular function in the central nervous system, acting as a coincidence detector that links synaptic activity to long-term changes in synaptic strength. Its dysfunction is associated with a broad spectrum of neurological and psychiatric disorders, including schizophrenia, depression, chronic pain, and neurodegenerative conditions. Moreover, the receptor is a target for pharmacological interventions, and understanding its regulation is critical for developing new therapies.
• Mediates excitatory synaptic transmission and synaptic plasticity.
• Acts as a coincidence detector for Hebbian learning and memory.
• Implicated in schizophrenia and psychotomimetic effects of NMDA antagonists.
• Involved in depression-like behaviors and antidepressant responses.
• Modulates cardiovascular responses when activated in the spinal cord.
• Regulates neuronal activity in the arcuate nucleus during inflammation.
• Contributes to behavioral changes in hyperammonemia and liver failure.
• Target for therapeutic development in neuropsychiatric disorders.
• Essential for differentiation of neural progenitors in fragile X syndrome.
• Regulates potassium channels via extrasynaptic NMDA receptors.
What Happens During NMDA glutamate receptor activity?
Ligand binding and co-agonist requirement
In simple terms: The receptor needs two keys to open: glutamate and either glycine or D-serine.
NMDA receptor activation requires binding of glutamate to the GluN2 subunit and glycine or D-serine to the GluN1 subunit. Without both ligands, the channel remains closed even if the membrane is depolarized. This dual requirement ensures that the receptor only opens under specific synaptic conditions.
Voltage-dependent Mg2+ block relief
In simple terms: At rest, a magnesium ion plugs the channel; depolarization pops it out.
At resting membrane potentials, extracellular Mg2+ occupies the channel pore, preventing ion flow. Membrane depolarization ejects Mg2+, allowing the channel to conduct cations. This indirect voltage gating is a hallmark of NMDA receptor activity and underlies its role in coincidence detection.
Ion permeation and calcium signaling
In simple terms: Once open, the channel lets calcium and other ions flow into the neuron.
Upon activation, NMDA receptors conduct Ca2+, Na+, and K+. The calcium influx is particularly important for triggering downstream signaling cascades that lead to synaptic plasticity, gene expression changes, and neuronal survival or death.
Modulation by extrasynaptic receptors
In simple terms: Receptors outside the synapse can also influence neuronal behavior.
Extrasynaptic NMDA receptors can modulate ion channels such as Kv2.1, affecting neuronal excitability. Glutamate transporters regulate the availability of glutamate at extrasynaptic sites, thereby influencing NMDA receptor activity.
Pharmacological modulation
In simple terms: Drugs can turn the receptor up or down, affecting behavior.
Agonists like NMDA activate the receptor, while antagonists such as phencyclidine block it. These pharmacological tools are widely used to study receptor function in vitro and in vivo, and to model psychiatric symptoms.
Key Genes Involved in GO:0004972 NMDA glutamate receptor activity
The following genes encode subunits and regulatory proteins that are essential for NMDA glutamate receptor activity.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GRIN1 | Encodes GluN1 subunit, obligatory for functional NMDA receptors | Knockout is lethal; point mutations linked to neurological disorders |
| GRIN2A | Encodes GluN2A subunit, modulates channel properties | Mutations associated with epilepsy and intellectual disability |
| GRIN2B | Encodes GluN2B subunit, enriched in extrasynaptic receptors | Target for neuroprotective strategies |
| GRIN2C | Encodes GluN2C subunit, expressed in cerebellum | Role in motor coordination and cerebellar plasticity |
| GRIN2D | Encodes GluN2D subunit, prominent in early development | Implicated in developmental disorders |
| GRIN3A | Encodes GluN3A subunit, modulates receptor trafficking | Regulates synaptic maturation |
| GRIN3B | Encodes GluN3B subunit, forms excitatory glycine receptors | Potential role in motor neurons |
| DLG4 | Encodes PSD-95, scaffolds NMDA receptors at synapses | Knockout alters synaptic plasticity |
| CAMK2A | Calcium/calmodulin-dependent kinase II, downstream effector | Critical for LTP and learning |
| SRC | Tyrosine kinase that phosphorylates NMDA receptor subunits | Modulates receptor activity |
| FYN | Tyrosine kinase that phosphorylates GluN2B | Regulates synaptic localization |
| PTK2B | Protein tyrosine kinase 2 beta, regulates NMDA receptor function | Linked to synaptic plasticity |
| GRIN2B | Alternative splice variants affect receptor properties | Splice variants studied in disease models |
| GRIN1 | Phosphorylation sites regulate trafficking and function | Phospho-mutant mice available |
| GRIN2A | RNA editing affects calcium permeability | Editing enzymes as therapeutic targets |
| GRIN2B | RNA editing and splicing generate diversity | Relevance to psychiatric disorders |
| GRIN2C | Post-transcriptional modifications influence function | Cerebellar research |
How Is NMDA glutamate receptor activity Regulated?
NMDA receptor activity is regulated at multiple levels, including phosphorylation by kinases such as Src and Fyn, which modulate channel properties and trafficking. Glutamate transporters control extracellular glutamate levels, thereby influencing receptor activation. Additionally, allosteric modulators and subunit composition dictate receptor kinetics and pharmacology. In pathological conditions, such as inflammation, phosphorylation of NR1 subunits is enhanced, leading to increased neuronal activity.
NMDA glutamate receptor activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GRIN2A | Epilepsy, intellectual disability | Knock-in mouse with patient mutation |
| GRIN2B | Schizophrenia, autism spectrum disorder | Conditional knockout in forebrain |
| GRIN1 | Schizophrenia, developmental delay | Point mutation knock-in |
| GRIN2C | Cerebellar ataxia | Knockout rat |
| GRIN3A | Neurodevelopmental disorders | Overexpression model |
Schizophrenia and Psychosis
NMDA receptor hypofunction is a leading hypothesis for schizophrenia. Phencyclidine, an NMDA antagonist, induces schizophrenia-like symptoms in healthy individuals. Modulation of NMDA receptor activity in the anterior cingulate cortex affects circuit oscillations relevant to psychosis.
Depression and Mood Disorders
NMDA receptor antagonists produce antidepressant-like effects in animal models, while NMDA agonists can block these effects. This suggests that NMDA receptor activity is critically involved in mood regulation and that targeting it may have therapeutic potential.
Neurodegeneration and Excitotoxicity
Excessive NMDA receptor activity leads to calcium overload and excitotoxicity, contributing to neuronal death in conditions such as stroke and neurodegenerative diseases. Extrasynaptic NMDA receptors are particularly linked to excitotoxic pathways.
Fragile X Syndrome
In fragile X syndrome, metabotropic glutamate receptor 5 responses dictate differentiation of neural progenitors to NMDA-responsive cells, highlighting a role for NMDA receptor activity in neurodevelopmental disorders.
From NMDA glutamate receptor activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Role of GluN2A in synaptic plasticity | GRIN2A knockout mouse |
| Effect of a patient mutation on receptor function | GRIN2B point mutation knock-in mouse |
| Subunit-specific contributions to behavior | Subunit-specific knockout rats |
| Receptor trafficking and localization | Tagged knock-in of GRIN1 |
| Consequences of receptor overexpression | Transgenic overexpression of GRIN2B |
| Pharmacological modulation in disease models | Knockout mice treated with NMDA antagonists |
How to Study the NMDA glutamate receptor activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Patch-clamp electrophysiology | Ion currents through NMDA receptors | Functional characterization of receptor variants |
| Calcium imaging | Intracellular calcium transients | Synaptic plasticity studies |
| Western blotting | Protein expression and phosphorylation | Subunit regulation |
| Immunohistochemistry | Receptor localization in tissue | Synaptic vs extrasynaptic distribution |
| Behavioral tests | Animal behavior after pharmacological manipulation | Depression and psychosis models |
| CRISPR knockout | Gene function loss | Subunit-specific roles |
| RNA sequencing | Transcriptional changes | Downstream signaling |
Electrophysiology
Patch-clamp recordings measure NMDA receptor currents and voltage dependence in neurons or heterologous cells. This method provides direct functional readout of channel activity.
Calcium Imaging
Fluorescent calcium indicators visualize NMDA receptor-mediated calcium influx in live cells. This technique is useful for studying receptor activation in synaptic plasticity.
Pharmacological Profiling
Agonists and antagonists are used to dissect receptor subtypes and contributions to behavior. For example, NMDA and phencyclidine modulate receptor activity in vivo.
Genetic Manipulation
CRISPR/Cas9-mediated knockout, knock-in, and point mutations allow precise interrogation of subunit function. These models are essential for linking specific genes to receptor activity.
How CRISPR Can Be Used to Study GO:0004972 NMDA glutamate receptor activity
Knockout
CRISPR knockout of NMDA receptor subunits, such as GRIN1 or GRIN2A, abolishes receptor function and allows researchers to study subunit-specific contributions to synaptic plasticity and behavior. These models are valuable for target validation.
Point Mutation
Introducing patient-associated point mutations into GRIN2A or GRIN2B via CRISPR enables precise modeling of receptor dysfunction in diseases like epilepsy and schizophrenia. Such models help dissect molecular mechanisms of disease.
Knock-in
Knock-in of tagged subunits (e.g., GFP-GluN1) facilitates real-time imaging of receptor trafficking and localization in neurons. This approach is powerful for studying dynamic regulation.
Overexpression
Overexpression of specific subunits, such as GRIN2B, using CRISPR activation or transgenic approaches can model conditions of receptor excess and study downstream effects. This is useful for gain-of-function studies.
How EDITGENE Supports NMDA glutamate receptor activity Research
Researchers studying NMDA glutamate receptor activity-related genes often need to determine whether a candidate gene is causally involved in receptor function, synaptic plasticity, or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to generate and characterize such models, from knockout to precise point mutations, enabling rigorous mechanistic and translational studies.
Contact EDITGENE today to design your custom CRISPR model for NMDA glutamate receptor activity research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| GRIN2B Knockout HEK293 Cell Line | EDJ-KQ668 | Human | 2904 | Details Get a Quote |
| GRIN3B Knockout HEK293 Cell Line | EDJ-KQ1135 | Human | 116444 | Details Get a Quote |
| GRIN1 Knockout HEK293 Cell Line | EDJ-KQ1219 | Human | 2902 | Details Get a Quote |
| GRIN2A Knockout HEK293 Cell Line | EDJ-KQ1220 | Human | 2903 | Details Get a Quote |
| GRIN2C Knockout HEK293 Cell Line | EDJ-KQ1576 | Human | 2905 | Details Get a Quote |
| GRIN2D Knockout HEK293 Cell Line | EDJ-KQ1577 | Human | 2906 | Details Get a Quote |
| GRIN3A Knockout HEK293 Cell Line | EDJ-KQ1814 | Human | 116443 | Details Get a Quote |
| GRIN2D Knockout A-549 Cell Line | EDJ-KQ19907 | Human | 2906 | Details Get a Quote |
| GRIN1 Knockout HCT 116 Cell Line | EDJ-KQ20548 | Human | 2902 | Details Get a Quote |
| GRIN2B Knockout A-549 Cell Line | EDJ-KQ20549 | Human | 2904 | Details Get a Quote |
| GRIN2B Knockout HCT 116 Cell Line | EDJ-KQ20550 | Human | 2904 | Details Get a Quote |
| GRIN2D Knockout HCT 116 Cell Line | EDJ-KQ21263 | Human | 2906 | Details Get a Quote |
| GRIN2D Knockout AGS Cell Line | EDJ-KZ271 | Human | 2906 | Details Get a Quote |
| GRIN1 Knockout HeLa Cell Line | EDJ-KQ53429 | Human | 2902 | Details Get a Quote |
| GRIN2A Knockout HeLa Cell Line | EDJ-KQ53430 | Human | 2903 | Details Get a Quote |
Displaying Records 1 To 15 Of 29 Records
Frequently Asked Questions About NMDA glutamate receptor activity
What is NMDA glutamate receptor activity?
NMDA glutamate receptor activity (GO:0004972) is a cation channel that opens in response to glutamate and glycine or D-serine binding when the membrane is depolarized, allowing ion flow.
What genes are involved in NMDA glutamate receptor activity?
Key genes include GRIN1, GRIN2A-D, and GRIN3A-B, which encode receptor subunits, as well as scaffolding and signaling genes like DLG4 and CAMK2A.
How is NMDA receptor activity regulated?
It is regulated by phosphorylation, glutamate transporters, and allosteric modulators, as well as subunit composition.
What diseases are associated with NMDA receptor dysfunction?
Schizophrenia, depression, epilepsy, neurodegenerative disorders, and fragile X syndrome have been linked to NMDA receptor dysfunction.
What are common research methods for studying NMDA receptors?
Patch-clamp electrophysiology, calcium imaging, pharmacological profiling, and CRISPR-based genetic manipulation are commonly used.
Can CRISPR be used to study NMDA receptor genes?
Yes, CRISPR knockout, knock-in, and point mutation models are powerful tools for dissecting NMDA receptor subunit functions.
What is the role of glycine in NMDA receptor activity?
Glycine is a co-agonist required for channel opening, binding to the GluN1 subunit.
How does magnesium block NMDA receptors?
At resting potentials, Mg2+ occupies the channel pore; depolarization ejects it, allowing ion flow.
What are extrasynaptic NMDA receptors?
These are receptors located outside the synaptic cleft that can modulate neuronal excitability and are often linked to excitotoxicity.
How does EDITGENE support NMDA receptor research?
EDITGENE offers CRISPR knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics services to study NMDA receptor genes.
Conclusion
NMDA glutamate receptor activity (GO:0004972) is a critical molecular function that underlies synaptic plasticity, learning, and memory, and its dysfunction is implicated in numerous neurological and psychiatric disorders. Understanding its mechanisms through genetic and pharmacological approaches is essential for developing targeted therapies. CRISPR-based models provide unprecedented opportunities to dissect subunit-specific roles and disease mechanisms. EDITGENE's comprehensive services empower researchers to accelerate discoveries in this field.
References
- 1. Honoré T et al.. 1988. Quinoxalinediones: potent competitive non-NMDA glutamate receptor antagonists.. Science 241(4866):701-3 PMID: 2899909
- 2. Dennis BH et al.. 2023. Modulation of circuit oscillations in the rat anterior cingulate cortex (ACC) in vitro by mGlu2 metabotropic glutamate receptors and alleviation of the effects of phencyclidine-induced NMDA-receptor hypofunction.. Pharmacol Biochem Behav 223:173532 PMID: 36822254
- 3. Mulholland PJ et al.. 2008. Glutamate transporters regulate extrasynaptic NMDA receptor modulation of Kv2.1 potassium channels.. J Neurosci 28(35):8801-9 PMID: 18753382
- 4. Hong YG et al.. 1992. Glutamate, NMDA and NMDA receptor antagonists: cardiovascular effects of intrathecal administration in the rat.. Brain Res 569(1):38-45 PMID: 1351773
- 5. Achuta VS et al.. 2017. Metabotropic glutamate receptor 5 responses dictate differentiation of neural progenitors to NMDA-responsive cells in fragile X syndrome.. Dev Neurobiol 77(4):438-453 PMID: 27411166
- 6. Peng JM et al.. 2011. Enhanced NMDA receptor NR1 phosphorylation and neuronal activity in the arcuate nucleus of hypothalamus following peripheral inflammation.. Acta Pharmacol Sin 32(2):160-6 PMID: 21293467
- 7. Poleszak E et al.. 2007. Activation of the NMDA/glutamate receptor complex antagonizes the NMDA antagonist-induced antidepressant-like effects in the forced swim test.. Pharmacol Rep 59(5):595-600 PMID: 18048961
- 8. Fedosiewicz-Wasiluk M et al.. 2005. The influence of NMDA, a potent agonist of glutamate receptor, on behavioral activity of rats with experimental hyperammonemia evoked by liver failure.. Amino Acids 28(1):111-7 PMID: 15700110
